Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CTSK | P43235 | 9/20 | 0.51 |
| ▸ | PREP | P48147 | 2/20 | 0.51 |
| ▸ | CTSL | P07711 | 3/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26276986 | 0.88 | CYP1A2 (0.55) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL607313 | 0.88 | CYP1A2 (0.55) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL28855000 | 0.88 | CYP1A2 (0.55) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL31723013 | 0.87 | CYP1A2 (0.56) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL11431644 | 0.82 | ALDH1A1 (0.61) | CYP1A2CTSKPREPELANEMEN1 | |
| SCHEMBL18800854 | 0.81 | CYP1A2 (0.61) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL11436545 | 0.81 | ALDH1A1 (0.59) | CYP1A2CTSKPREPCTSLELANE | |
| SCHEMBL28060962 | 0.80 | CYP1A2 (0.56) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL15081415 | 0.80 | CYP1A2 (0.56) | CYP1A2CTSKPREPCTSLCTSS | |
| SCHEMBL5400651 | 0.79 | CACNA1B (0.52) | CYP1A2CTSKCTSLCTSSCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013725-A1 | Amino acid derivatives | CACNA1B, SCN1A, SCN2A | CYP1A2 1895/4885CTSK 3691/4885PREP 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.